Free Trial

New Vernon Capital Holdings II LLC Has $9.35 Million Holdings in Bath & Body Works, Inc. $BBWI

Bath & Body Works logo with Retail/Wholesale background

Key Points

  • New Vernon Capital Holdings II LLC significantly increased its stake in Bath & Body Works, acquiring an additional 274,113 shares, resulting in total holdings worth approximately $9.35 million.
  • Bath & Body Works reported a quarterly EPS of $0.37, matching analyst expectations, while revenue for the quarter was $1.55 billion, also in line with forecasts.
  • The company announced a quarterly dividend of $0.20 per share, reflecting an annual yield of 2.5%, which will be paid to shareholders on September 5th.
  • Five stocks to consider instead of Bath & Body Works.

New Vernon Capital Holdings II LLC increased its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 2,932.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 283,462 shares of the company's stock after acquiring an additional 274,113 shares during the quarter. New Vernon Capital Holdings II LLC owned about 0.13% of Bath & Body Works worth $9,349,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in BBWI. T. Rowe Price Investment Management Inc. raised its holdings in Bath & Body Works by 7.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock worth $334,029,000 after purchasing an additional 781,681 shares during the last quarter. Victory Capital Management Inc. boosted its stake in shares of Bath & Body Works by 14,732.0% in the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock valued at $206,119,000 after purchasing an additional 6,752,274 shares during the last quarter. Alliancebernstein L.P. raised its stake in Bath & Body Works by 4.7% during the first quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company's stock worth $164,397,000 after buying an additional 243,611 shares during the last quarter. AQR Capital Management LLC raised its stake in Bath & Body Works by 267.8% during the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company's stock worth $121,073,000 after buying an additional 2,907,506 shares during the last quarter. Finally, GMT Capital Corp boosted its position in Bath & Body Works by 7.3% during the first quarter. GMT Capital Corp now owns 3,737,700 shares of the company's stock valued at $113,327,000 after acquiring an additional 255,600 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Trading Down 0.7%

Bath & Body Works stock traded down $0.19 during midday trading on Wednesday, reaching $28.03. The stock had a trading volume of 2,559,331 shares, compared to its average volume of 5,288,675. Bath & Body Works, Inc. has a 12 month low of $24.94 and a 12 month high of $41.87. The company has a market capitalization of $5.78 billion, a P/E ratio of 8.32, a PEG ratio of 0.98 and a beta of 1.49. The company has a fifty day moving average price of $30.63 and a two-hundred day moving average price of $30.36.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same period in the previous year, the company posted $0.37 EPS. The firm's revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. The ex-dividend date was Friday, August 22nd. This represents a $0.80 annualized dividend and a yield of 2.9%. Bath & Body Works's dividend payout ratio is presently 23.74%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on BBWI shares. The Goldman Sachs Group lowered their price objective on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. Barclays lifted their price objective on Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Friday, August 29th. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. Wells Fargo & Company boosted their price target on Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, May 14th. Finally, UBS Group dropped their price target on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating on the stock in a research note on Friday, August 29th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Bath & Body Works presently has a consensus rating of "Moderate Buy" and a consensus target price of $41.62.

Read Our Latest Research Report on Bath & Body Works

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Featured Stories

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.